Spectral AI, Inc. (MDAI) Research

Spectral AI, Inc. is an artificial intelligence (AI) firm specializing in AI-driven medical diagnostics. The company's primary goal is to facilitate faster and more accurate treatment decisions in wound care, particularly for patients dealing with burns and diabetic foot ulcers. Among its key products is DeepView, a predictive diagnostic device that delivers an objective and immediate evaluation of a wound's likely healing trajectory to clinicians, prior to any medical treatment or intervention. Spectral AI, Inc. is headquartered in Dallas, Texas.

Market snapshot

Symbol
MDAI
Price
$1.82
Day change
+0.55%
Market cap
$57.9M
P/E ratio
-4.04x
52-week range
1.18-3.21
Sector
Healthcare
Industry
Medical - Devices
Next earnings
in 2 months
Analyst price target
$4.00

Recent news

  • Spectral AI Stock Jumps After $31.7 Million Funding Award

    Here's what investors need to know.

Peer companies

  • Coeptis Therapeutics, Inc. (COEP)
  • Cytosorbents Corporation (CTSO)
  • electroCore, Inc. (ECOR)
  • Equillium, Inc. (EQ)
  • IceCure Medical Ltd (ICCM)
  • Century Therapeutics, Inc. (IPSC)
  • Karyopharm Therapeutics Inc. (KPTI)
  • Sensus Healthcare, Inc. (SRTS)

Recent insider activity

  • DiMaio John Michael — A-Award (15000 shares) on 2026-05-29
  • DiMaio John Michael — A-Award (2500 shares) on 2026-05-28
  • DiMaio John Michael — A-Award (32233 shares) on 2026-05-26
  • Sadagopan Deepak — A-Award (25000 shares) on 2026-04-24
  • Cotton Richard John — A-Award (8818 shares) on 2026-05-18

Open Spectral AI, Inc. (MDAI) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.